Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GME 40.00
warfaretrader, you made the best most accurate calls for months that I have seen anyone do on any stock in my 20 years of trading.
Very much appreciated by myself and many others.
Thank you and congrats on your 7 figure profit with CLWD.
Well deserved, congrats
Here is hoping GME has more grand slams for you as the game progresses.
The months seem to pass twice as fast when you get my age.
OK more than a year, what took so long lol
$GME 31.40 up 57% Congratulation sir.
You have been calling for this for months and were right.
Volume today was more than 18 times normal daily volume.
Well done
Already 4 times the normal daily volume
GME 29.00 up 45%
short covering leads to more short covering
Cramer and Ryan both buying today? lol
Very cool, maybe he will buy some and then mention GME on his show.
I emailed the SEC asking about the institutional and short numbers, no response yet.
I hope so, I want to know why this has increased like this without any pullback.
Only have about 10% of my original shares left and have stopped selling for now.
Nice find, thanks PhrmaBro
LOL that is crazy. Institutional Ownership 110.5%
I bought a starter here this morning.
The one thing I can't begin to understand is the short position here.
If all goes as planned the HGEN analysts will raise their price predictions multiple times this year. Eventually my guess is they all think we reach that 6B market cap.
Congrats on 1 year anniversary of retirement.
Thanks jay
That one stock went up 200% Thursday then another 99% Friday.
When that happens my exit strategy goes out the window.
I sold about 80% of the stock I had in that one.
I had held it for 11 months.
2020 was my second full year of retirement and I made more in the stock market than I ever made working for a living and this year is off to an even better start.
I have truly been blessed.
Its fun to see some of the local kids building their first ever snowman today. 2" of snow is a big event here.
Once covid calms down I plan on getting out and finding a nice home to buy in Round Rock. (A few miles north of Austin)
Would have happened already if not for covid.
Jay my exit strategy is a mirror image of the buy the dips and hold.
I plan to sell the tops a little at a time until I have my initial investment back. I'm guessing it will be 8 or 10 weeks still before I begin to sell a few. I'm very fortunate that some of my other stocks have jumped big the last few weeks and I am in no hurry to sell any here.
I know what you mean by being a hermit and not speaking much more than your doggie.
I was the foster parent to a dog, a lab until recently.
Agreed to foster for six months or so and it turned into 3 years.
There we many days since covid began that I only had doggie Harley to talk to.
Kind of miss him now but happy for him that he is back home where he wants to be.
Hope you and your daughters enjoyed the holidays.
It's snowing heavy in Austin today for the first time in years, nice to see.
Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19
January 10, 2021
Burlingame, CA, and Chicago, IL – January 10, 2021 – Humanigen, Inc. (HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug candidate lenzilumab™, and EVERSANA, a pioneer of next-generation services to the global life sciences industry, today announced that they are partnering to make lenzilumab available to hospitalized and hypoxic COVID-19 patients in the event that an Emergency Use Authorization is issued from the U.S. Food and Drug Administration (FDA) and subsequent BLA.
Humanigen’s investigational treatment, lenzilumab, a proprietary Humaneered® anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, is designed to prevent and treat cytokine storm, a complication considered to be a leading cause of COVID-19 death. Data showed that up to 89 percent* of hospitalized patients with COVID-19 are hypoxic and at risk of this immune hyper-response, which can trigger acute respiratory distress syndrome in severe cases of COVID-19.
Under the terms of the agreement, and in anticipation of an EUA for the use of lenzilumab in hospitalized COVID-19 patients, Humanigen has immediate access to EVERSANA’s fully integrated services including, but not limited to, marketing, market access, medical education, health economics and outcomes research, medical information, compliance and medical science liaison teams, with each service optimized by data and predictive analytics. The agreement with EVERSANA builds on the commercial preparation and lenzilumab launch planning Humanigen has been conducting over the last several months.
“EVERSANA shares our tireless commitment to patients,” said Cameron Durrant, MD, MBA, chief executive officer of Humanigen. “We’ve matched our dedication to research and development in COVID-19 with a proven commercialization partner to ensure lenzilumab will reach patients quickly and efficiently following a potential EUA.”
“We stand ready to immediately activate our services spanning all disciplines of the product journey to ensure lenzilumab delivers significant patient value,” said Jim Lang, chief executive officer of EVERSANA. “While EVERSANA’s model can be applied to any therapy or indication, we have a moral obligation to help COVID-19 patients in distress, knowing that even with the promise of vaccines there will be many patients who contract this virus and desperately need a treatment if hospitalized and hypoxic.”
*Source: National Institute of Allergy and Infectious Diseases’ Adaptive COVID-19 Treatment Trial (ACT-1)
https://www.humanigen.com/press/Humanigen-and-EVERSANA-Announce-Partnership-to-Support-the-Launch-and-Commercialization-of-Lenzilumab-for-the-Treatment-of-COVID-19
I hope that order executes within the next few weeks.
Sure feels like this is about to finally bust open.
Uplisting Could Improve Visibility to the Investment Community
SAN ANTONIO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- CloudCommerce, Inc. (CLWD), a leading provider of digital advertising solutions, today announced that it plans to up-list its common stock to the OTCQB® Venture Marketplace. The OTCQB is recognized by the Securities and Exchange Commission (SEC) as an established public market and provides current public information to investors that need to analyze, value, and trade securities.
The OTCQB increases transparency, reporting standards, management certification and compliance requirements, which can result in greater liquidity and awareness for companies that meet the OTCQB tier standard.
“Uplisting to the OTCQB is an important next step in our overall strategic plan to grow the Company and upgrade its position in the public markets,” said Andrew Van Noy, CloudCommerce, Inc. CEO. “We believe that trading on the OTCQB could potentially increase CLWD’s visibility to the investment community, particularly to institutional investors, as the Company continues to grow and establish itself as a leader in the industry. This broader acceptance and added liquidity should result in the expansion of our shareholder base while adding to shareholder value.”
About Cloud Commerce, Inc.
CloudCommerce, Inc. (CLWD) is a leading provider of digital advertising solutions. Our flagship solution, SWARM, analyzes a robust mix of audience data to help businesses find who to talk to, what to say to them, and how to market to them. We do this by applying advanced data science, behavioral science, artificial intelligence, and market research techniques to discover, develop and create custom audiences for highly targeted digital marketing campaigns. CloudCommerce was Ranked Number 235th Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500™. To learn more about CloudCommerce, please visit our website at www.CloudCommerce.com
Press Contact:
CloudCommerce, Inc.
Tel: (800) 673-0927
communications@cloudcommerce.com
Source: CloudCommerce, Inc.
Pink Current Information
Verified Profile 11/2020
Penny Stock Exempt
Transfer Agent Verified
Dollar volume at 19 million so far today.
Today's volume more than yesterdays record breaker.
Congrats allenc, well deserved payday.
Hope you continue to pick winners.
Thanks for all the accurate calls for several months war.
Just got home from the store and see it's at .07 so I sold a few more.
Wish I had not sold half yesterday but that's ok.
My account balance is at an all time high today, I am blessed.
I want to thank sello for the excellent dd he shared with the board for several months.
The info you shared was what convinced me to buy and kept me here.
Thank you sir and hope you are doing well.
Amazing day here and we don't know why
Hope the company communicates what is happening.
Actually I don't mind being kept in the dark as long as these kinds of gains continue.
Happy for you marinokv
The force is strong with CLWD today
This is crazy beautiful I love it.
Sold half my shares just missed long by a few weeks.
Bought them last Jan and Feb.
Holding the other half to see what happens next.
Congrats everyone, this is an awesome day
We all wish we had such a bid in
Yes, congrats to the lucky few
My account balance not looking so good at the moment lol
Red to Green morning
Dollar volume at 20 million today
Today is Friday but I know what you meant.
Beautiful chart, thanks for posting Golden_Cross.
Very bullish indeed.
Happy New Year
Anytime this year is OK with me
Deep wallets found out about COUV during the Christmas Holidays.
I'm glad they found it.
Belated Merry Christmas everyone.
Dollar volume over 9 million today already.
This is Beautiful.
agreed
Thanks for correcting me good to know.
I should have checked the calendar but didn't
I expected a red day today based on the chart but there is no reason for HGEN to be down this much on average volume.
No matter, I'm just a spectator with my shares firmly held.
Short trading week this week, just 3 and a half days.